Back to Scanner
CTNM
NASDAQRS 4Score 9Contineum Therapeutics, Inc. Class A Common Stock
HealthcareBiotechnology$501.80M
$12.96
-3.6% ($0.48)
-20.6% from 52W High
P/E (TTM)
-6.90
Fwd P/E
—
PEG
—
Analyst Upside
+8.0%
EPS Growth
—
Gross Margin
0.0%
ROE
-30.1%
D/E
0.03
Div Yield
0.0%
Avg Volume
124.4K
Price Chart
Key Levels
SMA 200
$10.69
SMA 50
$14.15
Price
$12.96
52W High
$16.32
Target
$14.00
Setup Radar
0/8 passing📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
⚡
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst